Calidi Biotherapeutics Risk Adjusted Performance
| CLDI Stock | | | 0.28 -0.02 -6.67% |
Technical inputs supporting the Risk Adjusted Performance indicator for Calidi Biotherapeutics are shown here. The information is based on observed market data across timeframes. Calidi Biotherapeutics has a market cap of 2.69 M. Allocation context is available in
Trending Equities. This captures an allocation to Calidi Biotherapeutics. How positions are weighted depends on the construction approach used. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in median.
Interested in buying Calidi Stock? See our
How to Buy Calidi Biotherapeutics guide. The guide includes approaches for both long-term investing and shorter-term trading of Calidi Stock. Whether buying or selling, the guide provides a structured framework for Calidi Biotherapeutics decisions.
Calidi Biotherapeutics has current Risk Adjusted Performance of
-0.20.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | -0.20 | |
Risk Adjusted Performance Peers Comparison
Risk Adjusted Performance Relative To Other Indicators
Calidi Biotherapeutics is rated
below average for risk adjusted performance among direct rivals. It is currently under evaluation for maximum drawdown among direct rivals .
Other Technical Indicators